Home / Market News / $ISRG
benzinga Corporate Catalyst Impact 55/100 ● negative

Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $400

Oct 21, 2026, 12:18 PM UTC · Primary ticker $ISRG

Mizuho analyst Anthony Petrone reiterated a Neutral rating on Intuitive Surgical (ISRG) and reduced its price target from $415 to $400. This indicates a slightly more cautious outlook from Mizuho, which could exert minor downward pressure on ISRG's stock in the short term.

Mizuho analyst Anthony Petrone maintained a 'Neutral' rating on Intuitive Surgical (ISRG) but lowered the price target from $415 to $400. This action reflects a slightly less optimistic view on the company's near-term valuation by Mizuho. While the 'Neutral' rating suggests no strong buy or sell recommendation, the reduced price target could signal concerns about growth prospects, competitive pressures, or broader market conditions affecting the medical device sector. For traders, this could lead to minor short-term selling pressure on ISRG as some investors might adjust their positions based on the revised target. Long-term implications are less clear, as a 'Neutral' rating doesn't fundamentally alter the investment thesis, but it does remove some upside potential in the analyst's view. A key risk for traders is if other analysts follow suit with similar price target reductions, creating a more significant negative sentiment.

$ISRG negative Price target lowered
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.